Revenue Agenda
  • Investing
  • Latest News
  • Editor’s Pick
  • Economy
  • Investing
  • Latest News
  • Editor’s Pick
  • Economy
No Result
View All Result
Revenue Agenda
No Result
View All Result
Home Editor's Pick

Biden administration to lower costs for 64 drugs through inflation penalties on drugmakers

by
June 28, 2024
in Editor's Pick
0
Biden administration to lower costs for 64 drugs through inflation penalties on drugmakers
0
SHARES
6
VIEWS
Share on FacebookShare on Twitter

The Biden administration on Wednesday said it will impose inflation penalties on 64 prescription drugs for the third quarter of this year, lowering costs for certain older Americans enrolled in Medicare. 

President Joe Biden has made lowering U.S. drug prices a key pillar of his health-care agenda and reelection platform for 2024. A provision of Biden’s Inflation Reduction Act requires drugmakers to pay rebates to Medicare, the federal health program for Americans over age 65, if they hike the price of a medication faster than the rate of inflation. 

It is separate from another provision under the law that allows Medicare to negotiate lower prescription drug prices with manufacturers. On average, Americans pay two to three times more than patients in other developed nations for prescription drugs, according to the Biden administration.

Some patients will pay a lower coinsurance rate for the 64 drugs covered under Wednesday’s announcement, which fall under Medicare Part B, for the period from July 1 to Sept. 30 “since each drug company raised prices faster than the rate of inflation,” according to a release from the administration.

Some Medicare Part B patients may save as much as $4,593 per day if they use those drugs during the quarter, the release added.  

More than 750,000 Medicare patients use the drugs each year, according to the release. The medications treat conditions such as cancer, certain infections and a bone disease called osteoporosis.

“Without the Inflation Reduction Act, seniors were completely exposed to Big Pharma’s price hikes. Not anymore,” Neera Tanden, White House domestic policy advisor, said in the release.

The Centers for Medicare & Medicaid Services plans to send the first invoices to drugmakers in 2025 for the rebates owed to the program.

In December, Biden released a list of 48 prescription drugs that would be subject to inflation penalties during the first quarter of 2024.

This post appeared first on NBC NEWS
Previous Post

Walgreens plans store closures as CEO says consumers ‘stunned’ by prices

Next Post

YouTube is dominating the living room, forcing media companies to decide whether it’s friend or foe

Next Post
YouTube is dominating the living room, forcing media companies to decide whether it’s friend or foe

YouTube is dominating the living room, forcing media companies to decide whether it’s friend or foe

  • Trending
  • Comments
  • Latest
Top 10 Potash Countries by Production (Updated 2024)

Top 10 Potash Countries by Production (Updated 2024)

August 21, 2024
Top 10 Cobalt Producers by Country (Updated 2024)

Top 10 Cobalt Producers by Country (Updated 2024)

September 19, 2024
Sen. Peter Welch says Israel ground invasion would ‘exacerbate’ conditions in Gaza: ‘Grave concerns’

Sen. Peter Welch says Israel ground invasion would ‘exacerbate’ conditions in Gaza: ‘Grave concerns’

October 24, 2023
Top 10 Phosphate Countries by Production (Updated 2024)

Top 10 Phosphate Countries by Production (Updated 2024)

August 1, 2024
Nuvau Minerals Inc. Announces Grant of Options

Nuvau Minerals Inc. Announces Grant of Options

0
New Hampshire Gov. Sununu signs $15.2B ‘miracle’ budget into law

New Hampshire Gov. Sununu signs $15.2B ‘miracle’ budget into law

0

Pennsylvania House clears tax credits for new teachers, nurses, police officers

0
Evers signs bipartisan sales tax bill aimed at sparing Milwaukee from bankruptcy

Evers signs bipartisan sales tax bill aimed at sparing Milwaukee from bankruptcy

0
Nuvau Minerals Inc. Announces Grant of Options

Nuvau Minerals Inc. Announces Grant of Options

May 30, 2025
Top 4 Vanadium-producing Countries

Top 4 Vanadium-producing Countries

May 30, 2025
Cardiex Completes Placement & Launches Entitlement Offer

Cardiex Completes Placement & Launches Entitlement Offer

May 30, 2025
CDX May Investor Presentation

CDX May Investor Presentation

May 30, 2025
Enter Your Information Below To Receive Trading Ideas and Latest News

Error: Contact form not found.

Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Recent News

Nuvau Minerals Inc. Announces Grant of Options

Nuvau Minerals Inc. Announces Grant of Options

May 30, 2025
Top 4 Vanadium-producing Countries

Top 4 Vanadium-producing Countries

May 30, 2025
Cardiex Completes Placement & Launches Entitlement Offer

Cardiex Completes Placement & Launches Entitlement Offer

May 30, 2025
CDX May Investor Presentation

CDX May Investor Presentation

May 30, 2025
  • About us
  • Privacy Policy
  • Terms & Conditions
  • About us
  • Privacy Policy
  • Terms & Conditions

Copyright © 2025 revenueagenda.com | All Rights Reserved

No Result
View All Result
  • Investing
  • Latest News
  • Editor’s Pick
  • Economy

Copyright © 2025 revenueagenda.com | All Rights Reserved